Prosecution Insights
Last updated: May 29, 2026

Examiner: FAROOQ, MAHMOOD

Tech Center 3700 • Art Units: 3783

This examiner grants 0% of resolved cases

Performance Statistics

0.0%
Allow Rate
-70.0% vs TC avg
17
Total Applications
+0.0%
Interview Lift
260
Avg Prosecution Days
Based on 1 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
3.6%
§102 Novelty
78.6%
§103 Obviousness
17.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18115714 INFUSION CARTRIDGE, INFUSION PUMP, CAP MEMBER, AND FLOW PATH CLOSURE ASSEMBLY Non-Final OA TERUMO KABUSHIKI KAISHA
17737956 INFUSION DEVICE AND METHOD WITH USER INTERFACE Final Rejection Fresenius Vial SAS
18212884 SUPPORT CATHETER WITH ENHANCED TORQUE RESPONSE AND HIGH PUSHABILITY Non-Final OA Boston Scientific Scimed, Inc.
18109508 MEDICAL DEVICE Final Rejection OLYMPUS MEDICAL SYSTEMS CORP.
18238595 Non-Integrated Vascular Access System with Stabilization Non-Final OA Becton, Dickinson and Company
18255293 APPARATUSES AND METHODS FOR NORMALIZING LOADED PUMP MOTOR DATA TO UNLOADED PUMP MOTOR DATA DURING A FLUID MOVEMENT OPERATION Non-Final OA Becton, Dickinson and Company
18237235 SYSTEMS AND METHODS FOR CONTROLLING PARTIAL DELIVERY PUMPING IN INFUSION SYSTEMS Non-Final OA Baxter Healthcare SA
18256441 METHODS AND DEVICES FOR PROVIDING OXYGEN TO ENCAPSULATED CELLS Non-Final OA CORNELL UNIVERSITY
18259081 SLOPE NEEDLE SET AND SLOPE NEEDLE INCLUDING MICRONEEDLE Non-Final OA INCYTO CO., LTD.
18117885 CLOSED-LOOP SODIUM ADMINISTRATION FOR TREATMENT OF CEREBRAL EDEMA Non-Final OA Naval Medical Research Command
16301137 NON-IMPLANT DEVICE FOR TEMPORARY OCCLUSION OF BLOOD VESSELS AND USE THEREOF Final Rejection SWISS VX VENENTHERAPIE UND FORSCHUNG GMBH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month